Ripretinib (QINLOCK®) According to Current SmPC

NCT06619275 · clinicaltrials.gov ↗

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

GIST - Gastrointestinal Stromal Tumor

Interventions

DRUG: Ripretinib

Sponsor

iOMEDICO AG

Collaborators

[object Object]